PYXS

PYXIS ONCOLOGY INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

PYXIS ONCOLOGY INC (PYXS) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$3.28M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 3 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders41 also report options

Congress trades0

Price$2.90vs quarter-end-3.65%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold3

Top holder

Renaissance Technologies

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $44.2K— of portfolio14,7002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$44.2K	14,700	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.